Skip to main content
TipRanks
Go Ultimate75% OFF

Robert Mulroy Insider Profile

4 Followers

Robert Mulroy, former President & CEO, Director at Merrimack Pharmaceuticals, holds 1.51M shares in Merrimack Pharmaceuticals (Ticker: MACK).

Robert Mulroy's Trading History

MACK
Merrimack Pharmaceuticals
Mar 25, 2015―Uninformative Sell1.34M$22.84M
MACK
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 25, 2015Uninformative Sell$1.34M458,380$11.70―
Mar 09, 2015Uninformative Sell$279.81K22,385$12.50―
Feb 20, 2015Uninformative Sell$1.64M150,000$10.94―
Dec 09, 2014Uninformative Sell$1.97M293,247$9.83―
Sep 02, 2014Informative Buy$24.79K19,832$1.25+41.70%

You May Also Like

Robert Mulroy insider profile FAQ

What is the percentage of profitable transactions made by Robert Mulroy?
The percentage of profitable transactions made by Robert Mulroy is 100%.
What is the average return per transaction made by Robert Mulroy?
The average return per transaction made by Robert Mulroy is 49.60%.
What stocks does Robert Mulroy hold?
Robert Mulroy holds: MACK stocks.
What was Robert Mulroy’s latest transaction?
Robert Mulroy’s latest transaction was an Uninformative Sell of $1.34M.
What was Robert Mulroy's most profitable transaction?
Robert Mulroy’s most profitable transaction was an Informative Buy of MACK stock on May 7, 2014. The return on the trade was 66.60%.
What is Robert Mulroy's role in Merrimack Pharmaceuticals?
Robert Mulroy's role in Merrimack Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.